Health Policy and Regulation
by Laura DeStefano | Apr 27, 2012 | Commentary, Perspectives
Health care in America is in crisis. Population health and patient outcomes are deteriorating relative to the rest of the developed world, and much of the health care delivered today is not based on rigorous scientific evidence. This is attributable, in large part, to...
by Laura DeStefano | Apr 20, 2012 | Discussion Paper, Perspectives
Introduction Over the past decade, the symbiotic relationship between the clinical trials enterprise (CTE) and the health care delivery system has been subject to increasing amounts of stress. During this period, the CTE has primarily focused on process improvement,...
by Laura DeStefano | Apr 6, 2012 | Commentary, Perspectives
With all the attention being paid to emerging accountable care organizations throughout the country, a California model is delivering measurable results. Catholic Healthcare West (CHW) (now Dignity Health), Hill Physicians Medical Group, and Blue Shield of California...
by Laura DeStefano | Feb 24, 2012 | Commentary, Perspectives
Amidst the politicized and polarized debate on health care policy, it is encouraging to know that the goal of this discussion remains unchanged; Republicans, Democrats, conservatives, and liberals all seem to agree that we should be working to create a high-value,...
by Laura DeStefano | Jan 28, 2012 | Commentary, Perspectives
I am pleased to introduce Perspectives, a new category of written products from the Institute of Medicine (IOM). Perspectives comprise two forms—commentaries and discussion papers—both of which offer observations and opinions of leading experts on developments in...
by Laura DeStefano | Jan 27, 2012 | Commentary, Perspectives
The challenging economics of health care require today’s innovators to demonstrate value against a number of criteria, including access to care, the current standard of care, and the economic capacity of payers. One way innovators have sought to address the paradox of...
by Laura DeStefano | Jan 27, 2012 | Commentary, Perspectives
In 1965, when Medicare was enacted, spending for prescription drugs was less than $4 billion—so low that no one thought to include a drug benefit as part of Medicare. By 2003, the cost and importance of drug therapy was so high that Medicare Part D was enacted. Drug...
by Laura DeStefano | Oct 1, 2011 | Discussion Paper, Perspectives
Abstract To generate needed improvements in health care, its delivery, and its outcomes, organized and sustained efforts at continuous improvement are needed. The Institute of Medicine’s Roundtable on Value & Science-Driven Health Care has developed the vision of...
Page 17 of 17« First«...10...1314151617
